Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Derek Archila is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/08/2024 | SLRN | Buy Now | Acelyrin | $4.88 | 166.39% | $13 → $13 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 06/24/2024 | ARGX | Buy Now | argenx | $459.12 | 18.05% | $478 → $542 | Maintains | Overweight | Get Alert |
| 06/18/2024 | ZNTL | Buy Now | Zentalis Pharma | $4.37 | 105.95% | $29 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/23/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $37.41 | 28.31% | $57 → $48 | Maintains | Equal-Weight | Get Alert |
| 05/15/2024 | ANNX | Buy Now | Annexon | $4.72 | 111.81% | $12 → $10 | Maintains | Overweight | Get Alert |
| 05/09/2024 | CCCC | Buy Now | C4 Therapeutics | $4.97 | 60.97% | $7 → $8 | Maintains | Equal-Weight | Get Alert |
| 05/09/2024 | ARVN | Buy Now | Arvinas | $26.63 | 125.31% | $63 → $60 | Maintains | Overweight | Get Alert |
| 05/03/2024 | ZYME | Buy Now | Zymeworks | $9.15 | 31.15% | $14 → $12 | Maintains | Overweight | Get Alert |
| 05/03/2024 | ASND | Buy Now | Ascendis Pharma | $137.79 | 90.14% | $260 → $262 | Maintains | Overweight | Get Alert |
| 04/18/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $44.72 | 16.28% | $53 → $52 | Maintains | Overweight | Get Alert |
| 04/11/2024 | ANAB | Buy Now | AnaptysBio | $25.00 | 124.04% | → $56 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | ANNX | Buy Now | Annexon | $4.72 | 154.17% | $12 → $12 | Maintains | Overweight | Get Alert |
| 03/27/2024 | ANNX | Buy Now | Annexon | $4.72 | 154.17% | $11 → $12 | Maintains | Overweight | Get Alert |
| 03/22/2024 | CABA | Buy Now | Cabaletta Bio | $7.62 | 359.39% | $34 → $35 | Maintains | Overweight | Get Alert |
| 03/21/2024 | SLRN | Buy Now | Acelyrin | $4.88 | 166.39% | $11 → $13 | Maintains | Equal-Weight | Get Alert |
| 03/15/2024 | ASND | Buy Now | Ascendis Pharma | $137.79 | 88.69% | $196 → $260 | Maintains | Overweight | Get Alert |
| 03/14/2024 | MOR | Buy Now | MorphoSys | $18.08 | 0.94% | $17 → $18.25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/12/2024 | ZYME | Buy Now | Zymeworks | $9.15 | 53.01% | $12 → $14 | Maintains | Overweight | Get Alert |
| 03/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $2.30 | 595.65% | $7 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/20/2024 | ARGX | Buy Now | argenx | $459.12 | 4.11% | $472 → $478 | Maintains | Overweight | Get Alert |
| 02/16/2024 | NRIX | Buy Now | Nurix Therapeutics | $21.06 | -5.03% | $23 → $20 | Maintains | Overweight | Get Alert |
| 02/05/2024 | MOR | Buy Now | MorphoSys | $18.08 | -5.97% | → $17 | Reiterates | Overweight → Overweight | Get Alert |
| 12/21/2023 | ARGX | Buy Now | argenx | $459.12 | 2.37% | $585 → $470 | Maintains | Overweight | Get Alert |
| 12/19/2023 | KYMR | Buy Now | Kymera Therapeutics | $39.25 | -33.76% | → $26 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/19/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.30 | 30.43% | $8 → $3 | Maintains | Equal-Weight | Get Alert |
| 12/19/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $44.72 | 18.52% | $48 → $53 | Maintains | Overweight | Get Alert |
| 12/19/2023 | BPMC | Buy Now | Blueprint Medicines | $116.52 | -1.3% | $86 → $115 | Maintains | Overweight | Get Alert |
| 12/19/2023 | ASND | Buy Now | Ascendis Pharma | $137.79 | 8.14% | $137 → $149 | Maintains | Overweight | Get Alert |
| 12/19/2023 | ARVN | Buy Now | Arvinas | $26.63 | 136.58% | → $63 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/15/2023 | MOR | Buy Now | MorphoSys | $18.08 | -5.97% | $10 → $17 | Maintains | Overweight | Get Alert |
| 12/14/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.41 | 44.35% | $67 → $54 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/13/2023 | SLRN | Buy Now | Acelyrin | $4.88 | 125.41% | → $11 | Initiates | → Equal-Weight | Get Alert |
| 11/14/2023 | KZR | Buy Now | Kezar Life Sciences | $0.56 | 254.48% | $4 → $2 | Maintains | Equal-Weight | Get Alert |
| 11/10/2023 | CLDX | Buy Now | Celldex Therapeutics | $36.35 | -25.72% | → $27 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/08/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $44.72 | -10.55% | $38 → $40 | Maintains | Overweight | Get Alert |
| 09/27/2023 | IMVT | Buy Now | Immunovant | $28.75 | 66.96% | $33 → $48 | Maintains | Overweight | Get Alert |
| 09/18/2023 | CABA | Buy Now | Cabaletta Bio | $7.62 | 411.89% | $14 → $39 | Maintains | Overweight | Get Alert |
| 09/15/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.41 | 71.08% | $34 → $64 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/06/2023 | ASND | Buy Now | Ascendis Pharma | $137.79 | -2.75% | $139 → $134 | Maintains | Overweight | Get Alert |
| 08/22/2023 | CLDX | Buy Now | Celldex Therapeutics | $36.35 | -42.23% | → $21 | Initiates | → Underweight | Get Alert |
| 08/11/2023 | KZR | Buy Now | Kezar Life Sciences | $0.56 | — | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/10/2023 | ZNTL | Buy Now | Zentalis Pharma | $4.37 | 1044.16% | $51 → $50 | Maintains | Overweight | Get Alert |
| 07/31/2023 | BPMC | Buy Now | Blueprint Medicines | $116.52 | — | $55 → $83 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 07/28/2023 | ARGX | Buy Now | argenx | $459.12 | 32.65% | $606 → $609 | Maintains | Overweight | Get Alert |
| 07/24/2023 | IMVT | Buy Now | Immunovant | $28.75 | 14.78% | $27 → $33 | Maintains | Overweight | Get Alert |
| 07/20/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.41 | 41.67% | $76 → $53 | Maintains | Equal-Weight | Get Alert |
| 06/20/2023 | DICE | Buy Now | DICE Therapeutics | — | — | $38 → $48 | Maintains | Equal-Weight | Get Alert |
| 06/16/2023 | MOR | Buy Now | MorphoSys | $18.08 | -5.97% | → $17 | Initiates | → Overweight | Get Alert |
| 06/14/2023 | BPMC | Buy Now | Blueprint Medicines | $116.52 | -52.8% | $48 → $55 | Maintains | Equal-Weight | Get Alert |
| 05/24/2023 | DICE | Buy Now | DICE Therapeutics | — | — | → $38 | Initiates | → Equal-Weight | Get Alert |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | $116.52 | -58.8% | $47 → $48 | Maintains | Equal-Weight | Get Alert |
| 05/12/2023 | KZR | Buy Now | Kezar Life Sciences | $0.56 | 2204.15% | $14 → $13 | Maintains | Overweight | Get Alert |
| 05/05/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.41 | 103.15% | $55 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/25/2023 | MORF | Buy Now | Morphic Holding | $55.71 | 43.6% | $67 → $80 | Maintains | Overweight | Get Alert |
| 03/21/2023 | ZYME | Buy Now | Zymeworks | $9.15 | 31.15% | → $12 | Assumes | → Overweight | Get Alert |
| 03/21/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.30 | 3247.83% | → $77 | Initiates | → Overweight | Get Alert |
| 03/09/2023 | EXEL | Buy Now | Exelixis | $22.09 | 4.12% | → $23 | Initiates | → Overweight | Get Alert |
| 01/03/2023 | KYMR | Buy Now | Kymera Therapeutics | $39.25 | 7.01% | $40 → $42 | Maintains | Overweight | Get Alert |
| 01/03/2023 | KZR | Buy Now | Kezar Life Sciences | $0.56 | 2381.39% | $17 → $14 | Maintains | Overweight | Get Alert |
| 01/03/2023 | INCY | Buy Now | Incyte | $60.60 | 23.76% | $72 → $75 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | CABA | Buy Now | Cabaletta Bio | $7.62 | 83.76% | $4 → $14 | Maintains | Overweight | Get Alert |
| 01/03/2023 | CCCC | Buy Now | C4 Therapeutics | $4.97 | 81.09% | $11 → $9 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | ASND | Buy Now | Ascendis Pharma | $137.79 | 28.46% | $169 → $177 | Maintains | Overweight | Get Alert |
| 01/03/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.41 | 55.04% | → $58 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/03/2023 | ARVN | Buy Now | Arvinas | $26.63 | 84% | $83 → $49 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/03/2023 | GLUE | Buy Now | Monte Rosa Therapeutics | $4.00 | 375% | → $19 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/03/2023 | BPMC | Buy Now | Blueprint Medicines | $116.52 | -64.81% | → $41 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 01/03/2023 | IMVT | Buy Now | Immunovant | $28.75 | -6.09% | $10 → $27 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/13/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | $118 → $116.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/08/2022 | MORF | Buy Now | Morphic Holding | $55.71 | 40.01% | $77 → $78 | Maintains | Overweight | Get Alert |
| 11/08/2022 | KYMR | Buy Now | Kymera Therapeutics | $39.25 | -8.28% | $35 → $36 | Maintains | Overweight | Get Alert |
| 11/08/2022 | IMVT | Buy Now | Immunovant | $28.75 | -65.22% | $7 → $10 | Maintains | Equal-Weight | Get Alert |
| 11/08/2022 | CCCC | Buy Now | C4 Therapeutics | $4.97 | 121.33% | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 11/07/2022 | ASND | Buy Now | Ascendis Pharma | $137.79 | 22.65% | $172 → $169 | Maintains | Overweight | Get Alert |
| 10/18/2022 | ARGX | Buy Now | argenx | $459.12 | 2.15% | $461 → $469 | Maintains | Overweight | Get Alert |
| 10/18/2022 | INCY | Buy Now | Incyte | $60.60 | 23.76% | $76 → $75 | Maintains | Equal-Weight | Get Alert |
| 09/22/2022 | ASND | Buy Now | Ascendis Pharma | $137.79 | 24.83% | $167 → $172 | Maintains | Overweight | Get Alert |
| 09/14/2022 | CABA | Buy Now | Cabaletta Bio | $7.62 | -47.5% | $14 → $4 | Maintains | Overweight | Get Alert |
| 08/29/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $51 → $71 | Maintains | Overweight | Get Alert |
| 08/17/2022 | BPMC | Buy Now | Blueprint Medicines | $116.52 | -64.81% | $40 → $41 | Maintains | Underweight | Get Alert |
| 08/04/2022 | MORF | Buy Now | Morphic Holding | $55.71 | 38.22% | $79 → $77 | Maintains | Overweight | Get Alert |
| 07/28/2022 | INCY | Buy Now | Incyte | $60.60 | 25.41% | → $76 | Initiates | → Equal-Weight | Get Alert |
| 06/28/2022 | KZR | Buy Now | Kezar Life Sciences | $0.56 | 2913.12% | $13 → $17 | Maintains | Overweight | Get Alert |
| 06/27/2022 | BPMC | Buy Now | Blueprint Medicines | $116.52 | -65.67% | → $40 | Initiates | → Underweight | Get Alert |
| 06/01/2022 | KYMR | Buy Now | Kymera Therapeutics | $39.25 | -10.83% | $62 → $35 | Maintains | Overweight | Get Alert |
| 05/31/2022 | NRIX | Buy Now | Nurix Therapeutics | $21.06 | 18.71% | → $25 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/13/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $53 → $51 | Maintains | Overweight | Get Alert |
| 05/13/2022 | KZR | Buy Now | Kezar Life Sciences | $0.56 | 2204.15% | $14 → $13 | Maintains | Overweight | Get Alert |
| 05/12/2022 | ASND | Buy Now | Ascendis Pharma | $137.79 | 27.73% | $190 → $176 | Maintains | Overweight | Get Alert |
| 05/05/2022 | MORF | Buy Now | Morphic Holding | $55.71 | 41.81% | $81 → $79 | Maintains | Overweight | Get Alert |
| 05/04/2022 | KZR | Buy Now | Kezar Life Sciences | $0.56 | 2381.39% | $19 → $14 | Maintains | Overweight | Get Alert |
| 04/11/2022 | NRIX | Buy Now | Nurix Therapeutics | $21.06 | 18.71% | $28 → $25 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | ZNTL | Buy Now | Zentalis Pharma | $4.37 | 1433.18% | → $67 | Initiates | → Overweight | Get Alert |
| 03/10/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $42 → $53 | Maintains | Overweight | Get Alert |
| 03/03/2022 | ASND | Buy Now | Ascendis Pharma | $137.79 | 23.38% | $176 → $170 | Maintains | Overweight | Get Alert |
| 02/10/2022 | KYMR | Buy Now | Kymera Therapeutics | $39.25 | 57.96% | → $62 | Initiates | → Overweight | Get Alert |
| 02/10/2022 | NRIX | Buy Now | Nurix Therapeutics | $21.06 | 32.95% | → $28 | Initiates | → Equal-Weight | Get Alert |
| 02/10/2022 | ARVN | Buy Now | Arvinas | $26.63 | 268.01% | → $98 | Initiates | → Overweight | Get Alert |
| 02/10/2022 | GLUE | Buy Now | Monte Rosa Therapeutics | $4.00 | 375% | → $19 | Initiates | → Equal-Weight | Get Alert |
| 02/10/2022 | CCCC | Buy Now | C4 Therapeutics | $4.97 | 403.02% | → $25 | Initiates | → Equal-Weight | Get Alert |
| 12/20/2021 | ARGX | Buy Now | argenx | $459.12 | -13.97% | — | Maintains | Overweight | Get Alert |
| 12/08/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $44.72 | -32.92% | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | IMVT | Buy Now | Immunovant | $28.75 | -68.7% | — | Initiates | → Equal-Weight | Get Alert |
| 12/08/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $37.41 | 124.54% | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | ARGX | Buy Now | argenx | $459.12 | -15.05% | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | ASND | Buy Now | Ascendis Pharma | $137.79 | 27.73% | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | CABA | Buy Now | Cabaletta Bio | $7.62 | 123.13% | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | KZR | Buy Now | Kezar Life Sciences | $0.56 | 3267.6% | — | Initiates | → Overweight | Get Alert |
| 12/08/2021 | MORF | Buy Now | Morphic Holding | $55.71 | 45.4% | — | Initiates | → Overweight | Get Alert |
| 03/17/2020 | DBVT | Buy Now | DBV Technologies | $0.80 | 648.13% | $36 → $12 | Downgrade | Buy → Hold | Get Alert |
| 01/09/2020 | DBVT | Buy Now | DBV Technologies | $0.80 | 2144.39% | $20 → $36 | Upgrade | Hold → Buy | Get Alert |
| 09/14/2018 | DBVT | Buy Now | DBV Technologies | $0.80 | 4264.09% | → $70 | Initiates | → Buy | Get Alert |
